ONAPGO is a prescription medicine used to treat motor fluctuations (OFF episodes) in adults with advanced Parkinson's disease (PD). It is not known if ONAPGO is safe and effective in children. Do not ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

A Sunderland man who was among the first in the world to have new brain implant technology to control his Parkinson's ...

ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's diseaseONAPGO is a wearable subcutaneous infusion devi ...

GLP-1 drugs showed neuroprotective effects in laboratory studies and in research on rats with brain injuries similar to those seen in Parkinson’s disease. This raised hopes that similar benefits ...

Traditional deep brain stimulation surgery can take up to 10 hours to complete, with the patient wide awake. This robotic ...

In a groundbreaking development for neurological care, scientists have unveiled an artificial intelligence-powered blood test that has the potential to detect Parkinson’s disease years before ...

"Neurotechnology" refers to a broad range of technologies designed to interface with the nervous system, with the aim of treating neurological disorders, enhancing cognitive function, and improving ...

Surgeons in Newcastle hope an adapted version of the deep brain stimulation system will have a "huge impact" on the quality ...

Richard Balanson says when one suffers a disease "you begin to accumulate friends" who have their own story with the same ...

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

The concept of a cognitive reserve is linked to lowering the risk of diseases such as Alzheimer's, Parkinson's, MS or having ...